In a market moving as quickly as AI, investors say that they aren't looking for companies with technology moats, but rather ...
23h
Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated ...
A new biotech start-up – Ouro Medicines – launched today with $120 million in funding from a Series A and a plan to develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback